Simona Saponara is an Associate Professor of Pharmacology at the University of Siena. She obtained a Master’s Degree in Pharmacy at the University of Siena in 1997. She received a Ph.D. in Molecular Pharmacology and Toxicology at the University of Siena in 2001. She was an Assistant Professor
of Pharmacology at the University of Siena from 2008 to 2021. She is a member of PhD in Life Sciences. She is a Library delegate for Dep of Life Science and a Member of the Board of the Library of Medical–Biological–Pharmaceutical area at the University of Siena. She is also a member of the Italian Pharmacological Society. She won the Young Researcher Award at the University of Siena in 2001. She was the Principal Investigator of the project "Optimization of oncology therapy: novel drugs affecting multi-drug resistance" (Futuro In Ricerca RBFR12SOQ1, 2013-2017) financed by the Italian Ministry of Education, University and Research and the Leader of the Working Group 4 "Pharmacokinetic and ADME/toxicology of new therapeutic tools; safety of therapeutic targets" of the Cost Action CA17104 "New diagnostic and therapeutic tools against multidrug resistant tumors".
Simona Saponara is an Associate Professor of Pharmacology at the University of Siena. She obtained a Master’s Degree in Pharmacy at the University of Siena in 1997. She received a Ph.D. in Molecular Pharmacology and Toxicology at the University of Siena in 2001. She was an Assistant Professor
of Pharmacology at the University of Siena from 2008 to 2021. She is a member of PhD in Life Sciences. She is a Library delegate for Dep of Life Science and a Member of the Board of the Library of Medical–Biological–Pharmaceutical area at the University of Siena. She is also a member of the Italian Pharmacological Society. She won the Young Researcher Award at the University of Siena in 2001. She was the Principal Investigator of the project "Optimization of oncology therapy: novel drugs affecting multi-drug resistance" (Futuro In Ricerca RBFR12SOQ1, 2013-2017) financed by the Italian Ministry of Education, University and Research and the Leader of the Working Group 4 "Pharmacokinetic and ADME/toxicology of new therapeutic tools; safety of therapeutic targets" of the Cost Action CA17104 "New diagnostic and therapeutic tools against multidrug resistant tumors".